kabutan

HISAMITSU PHARMA, 1% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 30 yen

Thu Apr 10, 2025 3:30 pm JST Earnings

4530 HISAMITSU PHARMACEUTICAL CO.,INC. 【J-GAAP】

Earnings Report

HISAMITSU PHARMACEUTICAL CO.,INC. <4530> [TSE Prime] announced its financial results after the market closed on April 10th (15:30). The consolidated ordinary profit for the fiscal year ending February 2025 increased 22.2% from the previous period to 24 billion yen. In the fiscal year ending February 2026, the profit is expected to grow by 1.2% to 24.3 billion yen. This will be the fifth consecutive term of revenue and profit growth.

At the same time, the company has decided to increase the dividend this fiscal year to 120 yen, an increase of 30 yen from the previous fiscal year.

In the most recent three-month period, from December to February (4Q), the consolidated ordinary profit surged 2.5 times that of the same period last year, reaching 7.53 billion yen. The operating profit margin drastically improved from 2.4% in the same period last year to 12.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2023 128,330 11,599 16,051 11,742 148.0 84.50 Apr 13, 2023 J-GAAP
Feb, 2024 141,706 13,167 19,649 13,969 181.6 85 Apr 11, 2024 J-GAAP
Feb, 2025 156,006 18,895 24,010 21,758 295.6 90 Apr 10, 2025 J-GAAP
YoY +10.1% +43.5% +22.2% +55.8% +62.7%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2025 Guidance 154,000 18,000 23,000 20,500 281.1 90 Jan 9, 2025 J-GAAP
Feb, 2025 Results 156,006 18,895 24,010 21,758 295.6 90 Apr 10, 2025 J-GAAP
Revision Rate +1.3% +5.0% +4.4% +6.1% +5.2%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar - Aug, 2024 75,456 9,006 10,788 9,098 122.7 45 Oct 10, 2024 J-GAAP
Mar - Aug, 2025 Guidance ー ー ー ー － 60 Apr 10, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb, 2024 141,706 13,167 19,649 13,969 181.6 85 Apr 11, 2024 J-GAAP
Feb, 2025 156,006 18,895 24,010 21,758 295.6 90 Apr 10, 2025 J-GAAP
Feb, 2026 Guidance 165,000 20,000 24,300 22,000 314.3 120 Apr 10, 2025 J-GAAP
YoY +5.8% +5.8% +1.2% +1.1% +6.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Dec - Feb, 2023 38,879 921 3,011 1,877 24.4 2.4 Apr 11, 2024 J-GAAP
Mar - May, 2024 35,810 4,149 5,562 4,788 63.9 11.6 Jul 11, 2024 J-GAAP
Jun - Aug, 2024 39,646 4,857 5,226 4,310 58.1 12.3 Oct 10, 2024 J-GAAP
Sep - Nov, 2024 35,797 4,214 5,683 4,562 61.8 11.8 Jan 9, 2025 J-GAAP
Dec - Feb, 2024 44,753 5,675 7,539 8,098 110.0 12.7 Apr 10, 2025 J-GAAP
YoY +15.1% +516.2% +150.4% +331.4% +350.9%

Related Articles